SARS-CoV-2 Saliva Test Now Available
MicroGEM and AiTmed have announced the MicroGEM Sal6830 SARS-CoV-2 Saliva Test is now available to AiTmed’s network of healthcare providers.
Read MorePosted by Chris Wolski | Sep 2, 2022 | Covid 19 |
MicroGEM and AiTmed have announced the MicroGEM Sal6830 SARS-CoV-2 Saliva Test is now available to AiTmed’s network of healthcare providers.
Read MorePosted by Chris Wolski | Sep 2, 2022 | Cancer, Molecular Diagnostics |
Exai Bio combines novel oncRNA technology with AI to develop next-generation liquid biopsy tests that will aid in the detection of cancer.
Read MorePosted by Tonya Manning | Sep 1, 2022 | Podcasts |
Of all the changes caused by the COVID-19 pandemic, the evolution of POC and home testing is perhaps the biggest. CLP Director of Business Intelligence Chris Wolski and Hamid Erfanian, CEO of Enzo Biochem, an integrated healthcare company focused on offering life sciences, including reagents, clinical testing and molecular diagnostic products, do a deep dive on the history of POC testing, how and why it became ubiquitous during COVID-19, and what this ubiquity means for the future of the clinical laboratory.
Read MorePosted by Andy Lundin | Sep 1, 2022 | Unknown Origin & Other Cancer Types |
Cedars-Sinai Cancer investigators have created a blood test that uses a technology to detect the most common form of liver cancer.
Read MorePosted by Andy Lundin | Aug 30, 2022 | Dementias & Alzheimer’s, Diagnostic Technologies |
Research shows how large-scale, sensor-based health monitoring can address age-related diseases and health problems that are discovered late.
Read More